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Summary
 
A null mutation was prepared in the mouse for CD18, the 
 
b
 
2
 
 subunit of leukocyte integrins.
Homozygous CD18 null mice develop chronic dermatitis with extensive facial and subman-
dibular erosions. The phenotype includes elevated neutrophil counts, increased immunoglobu-
lin levels, lymphadenopathy, splenomegaly, and abundant plasma cells in skin, lymph nodes,
gut, and kidney. Very few neutrophils were found in spontaneously occurring skin lesions or
with an induced toxic dermatitis. Intravital microscopy in CD18 null mice revealed a lack of
firm neutrophil attachment to venules in the cremaster muscle in response to 
 
N
 
-formyl-
methionyl-leucyl-phenylalanine. A severe defect in T cell proliferation was found in the CD18
null mice when T cell receptors were stimulated either by staphylococcal enterotoxin A or by
major histocompatibility complex alloantigens demonstrating a greater role of CD11/CD18
integrins in T cell responses than previously documented. The null mice are useful for delineat-
ing the functions of CD18 in vivo.
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eukocyte integrins play a major role in cell–cell and
cell–matrix interactions (1, 2). The 
 
b
 
2
 
 integrins include
LFA-1, macrophage antigen-1 (Mac-1),
 
1
 
 p150,95, and pos-
sibly a fourth form (3); each functions as heterodimeric
molecules, with a separate 
 
a
 
 chain (CD11a, b, c, or d) and
a common 
 
b
 
 chain (CD18). These leukocyte receptors are
of importance in adhesion and signaling in a variety of
physiological and pathological conditions.
Substantial information is available regarding the com-
plex cellular function of CD18 based on studies using
blocking antibodies and on analysis of genetic deficiencies
in humans and in cattle (4–7). The human disorder is
known as leukocyte adhesion deficiency type I (LAD I),
and is caused by heterogeneous mutations in CD18. CD18-
deficient patients suffer from recurrent microbial infections,
leukocytosis, impaired wound healing, and lack of pus for-
mation. A hypomorphic mutation in CD18 was generated
in mice earlier by gene targeting, and homozygotes dis-
played 2–16% of normal levels of CD18 on leukocytes (8).
This hypomorphic CD18-deficient mouse does not show
spontaneous infections as occur in LAD I patients; how-
ever, when this mutation was backcrossed onto PL/J in-
bred strain, homozygous mice developed a dermatitis re-
sembling human psoriasis (9). Although the hypomorphic
mutation is valuable for assessing the effect of reduced ex-
pression of 
 
b
 
2
 
 integrins in chronic inflammatory processes,
it is less valuable for functional evaluation of the role of
CD18, since animals are not completely deficient for
CD18. Human CD18 deficiency includes a range of sever-
ity that overlaps the phenotypes seen with the mouse hy-
pomorphic and null mutations, with many severely affected
and some mildly affected patients (7).
We report here the characterization of mice completely
deficient in CD18 that were generated by homologous re-
combination in embryonic stem (ES) cells. In contrast to
CD18 hypomorphic mutant mice (8), CD11a-deficient
 
1
 
Abbreviations used in this paper:
 
 DNFB, dinitrofluorobenzene; ES cell, em-
bryonic stem cell; ICAM-1, intercellular adhesion molecule-1; LAD, leu-
kocyte adhesion deficiency; Mac-1, macrophage antigen-1; OpZ, op-
sonized zymosan; SE, staphylococcal enterotoxin; ZAS, zymosan activated
serum.
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CD18 Null Mutation in Mice
 
mice (10), and CD11b-deficient mice (11, 12), the CD18
null mice reveal a phenotype closely resembling LAD I pa-
tients, including spontaneous occurrence of mucocutane-
ous infections. These CD18 null mice provide the first mu-
rine model of severe human LAD I and reveal a prominent
requirement for CD18 integrins in T cell activation by staph-
ylococcal enterotoxin A or by MHC alloantigens.
 
Materials and Methods
 
Targeting Construct and Generation of Mutant Mice.
 
We have used
a previously published (8) targeting construct with a 
 
z
 
10-kb seg-
ment of the CD18 gene containing exon 2 and 3 and a neomy-
cin-resistance gene (neo) cassette with a short version of the
RNA polymerase II promoter and the bovine growth hormone
polyadenylation signal; the neomycin cassette thus, disrupts the
splice-acceptor site of exon 3 (8). The AB1 ES cell line was elec-
troporated (13) with the construct after digestion with KpnI for
use as a replacement vector. Digestion with HindIII was used to
identify homologous recombinants on Southern blots hybridized
with the 3
 
9
 
 flanking probe as indicated (Fig. 1 
 
A
 
). The mutation
resulted in a 
 
z
 
6.5-kb HindIII fragment compared with a 5.0-kb
HindIII fragment for the wild-type genomic DNA. Embryonic
stem cells confirmed by Southern blotting to carry the replace-
ment mutation were used for germline transmission which was
confirmed by Southern blot analysis of tail DNA using HindIII
digestion and the 3
 
9
 
 flanking probe. Progeny containing the mu-
tant CD18 allele were intercrossed resulting in CD18 homozy-
gous mutant pups. The results presented are from mice of mixed
129/Sv and C57BL/6J background. For all experiments, ho-
mozygous progeny and wild-type littermates from heterozygous
intercrosses were used. Sentinel mice housed in the same rooms
at the barrier facility as the CD18 null mice repeatedly tested neg-
ative for common viruses.
 
Histopathology.
 
A total of 33 animals were examined repre-
senting three age groups, both sexes, and both homozygous and
wild-type mice. Affected and control mice were killed for histo-
logical analysis and 32 different tissues were fixed in 10% (vol/
vol) neutral buffered formalin supplemented with zinc chloride.
Paraffin-embedded sections were stained with hematoxylin-eosin.
 
Peripheral White Blood Cell Counts.
 
Mice were bled from the
retroorbital sinus into EDTA-anticoagulated tubes while under
anesthesia. Total white blood cell counts and differential leuko-
cyte counts were determined using a Technicon H.1 analyzer (Miles
Diagnostics, Elkhart, IN) calibrated for analysis of murine sam-
ples. Blood smears were prepared with Wright’s stain.
 
Microbiological Analyses.
 
For bacterial culture, sterile swabs
were moistened in phosphate-buffered saline containing 0.1%
Triton X-100 and used to scrub the area for inoculation onto
Columbia sheep blood agar plates. Swabs were also inoculated
onto Mycosel agar and incubated at 25
 
8
 
C for 1 mo for the culture
of fungi. Swabs also were inoculated on Löwenstein Jensen’s agar
and incubated at 30
 
8
 
C for 2 mo for isolation of mycobacteria.
 
Susceptibility to Streptoccus pneumoniae Infection.
 
Wild-type and
CD18 null mice aged 8 wk were inoculated intraperitoneally
with a single 0.1-ml dose (6–8 
 
3
 
 10
 
6
 
 CFU/ml) of 
 
S. pneumoniae
 
as described in detail elsewhere (14). Blood (10 
 
m
 
l) was obtained
by nicking the tail vein using sterile technique for culture by in-
oculation on blood agar incubated at 35
 
8
 
C. The degree of bacter-
emia was characterized by the number of CFU on the blood cul-
ture plate. Statistical analyses were performed using Kaplan Meier
and log rank analysis for bacterial load, presence or absence of
bacteremia, and mortality.
 
Cell Staining and Flow Cytometry.
 
Peripheral blood was col-
lected from homozygous mutants or littermate controls from the
retroorbital sinus with EDTA anticoagulation. Expression of
CD18 was determined by immunostaining with a fluorescein
isothiocyanate-conjugated anti-CD18 mAb (C71/16; PharMingen,
San Diego, CA). Also, 4 
 
3
 
 10
 
5
 
 fresh splenocytes or thymocytes
were stained with 1 
 
m
 
g of FITC-conjugated and/ or PE-conju-
gated CD3, CD4, and CD8-specific or isotype control antibodies
for 20–30 min on ice and fixed with 1% paraformaldehyde. Cell
surface phenotype was determined by immunofluorescent analysis
with an EPICS Profile flow cytometer (Coulter Immunology,
Hialeah, FL).
 
Toxic Dermatitis.
 
Six sex-matched mutant and wild-type ani-
mals were used at 7– 9 wk of age. The irritant response was initi-
ated by applying 10 
 
m
 
l of 2% (vol/vol) dinitrofluorobenzene
(DNFB; Sigma Chemical Co., St. Louis, MO) in olive oil to the
dorsal and ventral aspects of the right ear. The resulting inflam-
matory response was monitored by microscopic examination at 5 h
after DNFB application.
 
Intravital Microscopy.
 
Three CD18 null mice and three wild-
type littermate controls were anesthetized with an i.p. injection of
ketamine hydrochloride (100 mg/kg, Ketalar; Parke-Davis, Morris
Plains, NY) after premedication with sodium pentobarbital (30
mg/kg, Nembutal; Abbott Laboratories, Chicago, IL,) and atro-
pine (0.1 mg/kg, Elkins-Sinu, Cherry Hill, NJ) i.p. The trachea,
left jugular vein, and left carotid artery were cannulated to facili-
tate respiration and allow injection of anesthetic, measurement of
blood pressure, and blood sampling. Blood pressure was moni-
tored continuously (model BPMT-2; Stemtech, Inc., South Na-
tick, MA) and carotid blood samples were drawn at the beginning
and end of the observation period. Mice were thermocontrolled
using a small animal heating pad (model 50-7503; Harvard Appa-
ratus, Inc., South Natick, MA) and received anesthetic as required
to maintain blood pressure in the range 60–100 mm of Hg.
The cremaster muscle was prepared for intravital microscopy as
described (15). During surgery (typically 10 min) and data collec-
tion, the cremaster was superfused with thermocontrolled (37
 
8
 
C)
bicarbonate-buffer (132 mM NaCl, 4.7 mM KCl, 2 mM CaCl
 
2
 
,
1.2 mM MgCl
 
2
 
, and 18 mM NaHCO
 
3
 
 equilibrated with 5%
CO
 
2
 
 in N
 
2
 
 to adjust pH to 7.35).
Microscopic observations were made up to 1 h after exterior-
ization of the cremaster using a (Carl Zeiss Inc., Thornwood,
NY) intravital microscope with a saline immersion objective
(SW40.0.75 numerical aperture). Venules with diameters be-
tween 20 and 40 
 
m
 
m were observed and recorded through a
CCD camera system (model VE-1000CD; Dage-MTI, Inc.,
Michigan City, IN).
Glass micropipettes were drawn from standard borosilicate
glass (outer diameter 1.0 mm; Stoelting, Wood Dale, IL) on a
vertical micropipette puller (Stoelting) and beveled to a tip diam-
eter of 7–10 
 
m
 
m using a micropipette grinder (model EG-40;
Narishige, Sea Cliff, NY) with 0.3 
 
m
 
m abrasive foil (no. 6775;
A.H. Thomas, Philadelphia, PA). The pipettes were filled with
 
z
 
15 
 
m
 
l of filtered (0.45 
 
m
 
m, Millex HV4; Millipore Corp., Bed-
ford, MA) 10 
 
m
 
M fMLP (Sigma Chemical Co.) solution. An air-
tubing and syringe system attached to the pipette holder served as
a pressure reservoir controlled by a 10-ml syringe and allowed
continuous, stable microinfusions. Venules were selected for in-
jection on the basis of size (20–40 
 
m
 
m) and presence of baseline
rolling with little or no firm adhesion of cells; these venules were
recorded for 60 s before placement of the pipette. A pipette was 
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placed in proximity (within 40 
 
m
 
m) to the observed vessel using a
piezo-driven micromanipulator (model DC-3K; Märzhäuser-Wetz-
lar, Upper Saddle River, NJ) with the beveled tip penetrating the
interstitial tissue. The vessel was recorded for 60 s in the presence
of the pipette tip without infusion. No difference was seen be-
tween the number of firmly adhered cells before and after pipette
placement (data not shown). Microinfusion of 10 
 
m
 
M fMLP which
caused a slight swelling of the impaled interstitial tissue, was initi-
ated by application of pressure to the air-tubing system and was
maintained for 60 s. The vessel was recorded for a further 60 s af-
ter termination of microinfusion.
The number of firmly adhered leukocytes in the observed ves-
sel was counted off-line at four time points; (
 
a
 
) after 60 s record-
ing, (
 
b
 
) after 60 s 
 
1
 
 pipette, (
 
c
 
) after 60 s fMLP infusion, and (
 
d
 
)
60 s after termination of fMLP. Length and diameter of the ob-
served vessel was measured using a commercial digital image pro-
cessing system (Macintosh 7100 computer video capture board
Scion Corporation, Frederick, MD). Results are presented as
number of firmly adhered cells/100 
 
m
 
m of vessel length. Rolling
leukocyte fluxes were also determined for the four observation
periods by counting the number of leukocytes distinguishable
from the blood stream passing a line perpendicular to the vessel
axis. For this purpose, the video tapes were replayed at one half to
one-fifth original speed. Counting visibly distinguishable cells is
widely used for analysis of leukocyte rolling and is known to be
accurate at blood flow velocities above 0.5 mm/s (16). Vessels
with flow velocities below 0.5 mm/s were not studied as it is dif-
ficult to distinguish rolling cells from free flowing cells at lower
flow rates. Total leukocyte flux through a given venule was esti-
mated as a product of systemic leukocyte count and volumetric
flow rate of blood through the venule (calculated using microves-
sel diameter and mean blood flow velocity assuming cylindrical
geometry). Leukocyte rolling flux fraction is defined as the flux of
rolling leukocytes as a percentage of total leukocyte flux and is
thus independent of variation in systemic leukocyte counts.
 
In Vitro Adherence Assay for Neutrophils.
 
Neutrophils from mu-
tant mice and wild-type littermates were isolated from bone mar-
row as described (12). A visual adherence assay was used for
quantitating adhesion of murine neutrophils to KLH-coated glass,
a surface to which neutrophils adhered only after stimulation (17).
Briefly, neutrophils were preincubated at 37
 
8
 
C for 10 min and
exposed to zymosan activated serum (ZAS) for an additional 10
min in the presence or absence of a saturating level of antibody (5
 
m
 
g/ml) before injection into the adherence chambers. Cells were
allowed to settle for 500 s and inverted for 500 s; the percent ad-
herence was determined by counting 5–10 high power fields per
experimental condition.
 
Assays of Luminal-enhanced Chemiluminescence.
 
The evolution
of light from neutrophils undergoing iC3b-mediated phagocyto-
sis after activation by opsonized zymosan particles was quantitated
as described previously (18). Zymosan particles (ICN Pharmaceu-
ticals, Irvine, CA) were opsonized in freshly obtained serum from
healthy mice for 45 min at 37
 
8
 
C. Opsonized zymosan particles
were then washed three times and resuspended in PBS to a final
concentration of 0.5 mg/ml. Phagocytotic reaction mixtures con-
tained 10
 
6
 
 neutrophils with 10
 
2
 
8
 
 M luminal. Chemiluminescence
was quantitated after the addition of PBS or 0.5 
 
m
 
g/ml of op-
sonized zymosan particles to reaction mixture.
 
T Cell Proliferation Upon Stimulation with SEA or Mixed Lympho-
cyte Reaction.
 
Splenocytes were treated with low ionic strength
media and Tris ammonium chloride to remove dead cells and red
blood cells, respectively (19). 4 
 
3
 
 10
 
5
 
 cells/well were plated in
96-well round bottom microtiter plates in a total volume of 200 
 
m
 
l
in supplemented Dulbecco’s Modified Eagle’s medium (sDME)
with 10% FCS (19). The cells were cultured alone or with SEA at
0.1 ng/ml to 20 
 
m
 
g/ml (Toxin Technology, Sarasota, FL) for 96 h
and labeled with [
 
3
 
H]thymidine (DuPont-NEN, Boston, MA)
for the last 5–6 h. They were processed for liquid scintillation
counting (Betaplate, Wallace, Gaithersburg, MD) and the result-
ing data expressed as mean cpm 
 
6 
 
SEM of triplicate cultures.
CD18 null and wild-type splenocytes (4 
 
3
 
 10
 
5
 
 cells/well)
were also stimulated in the MLR by increasing concentrations of
allogeneic BALB/c (H-2
 
d
 
) or syngeneic CD18 null or wild-type
control (H-2
 
b
 
) spleen cells that had been irradiated to 1,500 rads.
MLR were labeled and harvested as above after 96 h culture in
10% sDME with 10 
 
m
 
M 2-mercaptoethanol (Sigma Chemical
Co.), in round bottom microtiter plates. CD18 null and wild-
type splenocytes were also stimulated with ionomycin (200 ng/ml)
and phorbol 12-myristate 13-acetate (1 ng/ml; Sigma Chemical
Co.), and were labeled and harvested at 24-h intervals through
120 h of culture.
 
Determination of Immunoglobulin and Cytokine Levels.
 
Serum im-
munoglobulin isotypes were determined by sandwich ELISA as
previously described (20). Bioassays for IL-3, GM-CSF, and IL-6
were performed as described previously (21, 22).
 
Results
 
Generation of a CD18 Null Mutation in Mice.
 
To introduce
a null mutation into the CD18 locus, a previously reported
targeting construct (8) that was used to introduce a duplica-
tion resulting in a hypomorphic allele was now used to
produce a replacement mutation (Fig. 1 
 
A
 
). The construct
contains the neomycin-resistance cassette disrupting the 5
 
9
 
boundary of exon 3, thus preventing any synthesis of nor-
mal CD18 protein. Using Southern analysis, recombinant
colonies were found with a frequency of 1 in 125 among
the G418-resistant clones. The mutation was transmitted to
the germline, and heterozygous mutant mice were inter-
crossed. Homozygous mutant (hereafter referred to as CD18
null) mice were detected by Southern blotting (Fig. 1 
 
B
 
) at
3 wk of age at a lower than expected frequency ranging
from 12 to 18% of 102 progeny tested over different inter-
vals. However, when performing Southern blot analysis of
18-d-old embryos, an expected frequency of 25% was ob-
tained, suggesting that some CD18 null offspring die perina-
tally. As a quantitative assessment of cell surface expression
of CD18, FACS
 
Ò
 
 analysis of leukocytes was performed
(Fig. 1 
 
C
 
). Surface expression of CD18 was found on leu-
kocytes from wild-type animals, but there was no detect-
able expression of CD18 on leukocytes from CD18 null mice.
The function of CD18 was assessed by measuring the
ability of neutrophils to attach to KLH-coated glass and to
generate an oxidative burst after exposure to chemoattrac-
tants; this method reveals a severe deficit in CD18-deficient
human cells (17). There was almost no adhesion of neutro-
phils from wild-type or CD18 null mice without stimula-
tion, but exposure of neutrophils to zymosan activated se-
rum, which is rich in C5a, resulted in a substantial increase
in adhesion of neutrophils derived from wild-type mice
(Fig. 2 
 
A
 
). By contrast, no significant neutrophil adhesion
was observed with cells from CD18 null mice. Neutrophil122 CD18 Null Mutation in Mice
adhesion of wild-type mice was substantially abrogated by
blocking antibodies against CD11b, whereas blocking anti-
bodies against CD11a and an isotype-matched rat IgG did
not affect neutrophil binding to KLH (Fig. 2 A). Similar
results were obtained for phagocytosis associated oxidative
burst that earlier had been shown to be Mac-1 (CD11b/
CD18) dependent (23). The evolution of light by neutro-
phils in association with iC3b mediated phagocytosis was
quantitated by a luminal-enhanced chemiluminescence as-
say (23). Neutrophils isolated from wild-type mice exhib-
ited substantial chemiluminescence when mixed with op-
sonized zymosan particles, whereas neutrophils from CD18
null mice did not exhibit significant activity (Fig. 2 B). The
absence of surface expression of CD18, the lack of neutro-
phil adhesion, and the deficiency of oxidative burst are
consistent with the complete disruption of the CD18 mol-
ecule.
The Phenotype of Homozygous CD18 Null Mice Resembles
Human LAD I. At various times in managing the mouse
colony, 10–40% of the newborn CD18 null animals died
perinatally. The surviving CD18 mutant mice developed
progressive perioral soft tissue swelling, facial alopecia, red-
dening of the skin, and extended facial and submandibular
ulcerative dermatitis at z3 mo of age (Fig. 3, A and B).
This phenotype was observed in 95% (48 of 51) of mice on
a mixed 129/Sv and C57BL/6J background.
Histopathology of the skin revealed superficial erosions
and ulcerations covered by an eosinophilic crust with en-
trapped necrotic inflammatory cells and bacterial colonies
(Fig. 3 C). The dermis beneath and adjacent to the erosions
revealed a predominantly mononuclear inflammatory cell
infiltrate consisting of lymphocytes, histiocytes, and occa-
sional perivascular plasma cells with far fewer neutrophils
than would be expected in a wild-type animal at a site of
bacterial infection, suggesting that neutrophil extravasation
into the interstitial tissue is severely impaired (Fig. 3 C).
Affected mice also displayed splenomegaly with a 2.5-fold
increase in weight (data not shown) due to a myeloid hy-
Figure 1. Preparation and analysis of the CD18 null mutation. A shows the genomic region to be targeted above with the targeted mutation below.
DNA length is drawn to scale and the first three exons are indicated as solid rectangles. The location of the 39 and 59 flanking probes are shown as hatched
boxes. Restriction enzyme sites are indicated as follows: E, EcoRI; H, HindIII; K, KpnI; and P, Pst. The targeting vector was linearized with KpnI, and
a replacement mutation was obtained with insertion of a neomycin cassette at a PstI site that occurs precisely at the boundary of the intron and the 59 end
of exon 3. B shows a Southern blot with the 39 flanking probe and genomic DNA isolated from the tails of wild-type (1/1), homozygous CD18 null (2/2),
and heterozygous (1/2) mice. C presents the analysis of expression of CD18 on the surface of leukocytes from wild-type and homozygous CD18 null
mice. FACSÒ analysis was performed as described in Materials and Methods. An isotype-matched control antibody was used (top). Expression of CD18
was quantitated by immunostaining with FITC-conjugated mAb C71/16.123 Scharffetter-Kochanek et al.
perplasia within the red pulp; similar hyperplasia was
present in the bone marrow of CD18 null mice. Occa-
sional inflammatory lesions were noted in mutant mice in
heart, salivary gland, liver, and intestine. No consistent pat-
tern was noted, and these lesions were usually associated with
concurrent cutaneous disease. In addition, a reactive lym-
phadenopathy predominantly involving nodes that drain the
anatomical sites of skin erosions was observed. The major
histological abnormality in these nodes was an accumula-
tion of plasma cells, some revealing periodic acid-Schiff
(PAS)-positive inclusions (Russell bodies) indicative of in-
creased immunoglobulin deposition. At 2.5–3 mo of age,
serum total IgG, IgG1, IgG2a, and IgG2b were increased
10–15-fold in CD18 null mice compared with wild-type
littermates (Table 1). CD18 null mice showed significant
but more modest increases in IgG3, IgM, and IgA. Plasma
cell infiltration with Russell body formation was also ob-
served in spleen (Fig. 3 D), kidney, small intestine, iliac
lymph nodes, and the dermis and subcutaneous tissue of the
skin from the dorsum of the head, shoulders, and the dor-
sum of the neck. Numbers of circulating leukocytes in
CD18 null mice were increased up to sixfold compared
with littermates (Table 2).
Increased circulating leukocyte counts were largely due
to elevated numbers of circulating neutrophils, but lym-
phocyte and monocyte numbers were also increased. The
neutrophils revealed hypersegmentation and appendix for-
mation of the nuclei. Since IL-3 and GM-CSF have been
shown to stimulate granulopoesis (21) and IL-6 to prevent
apoptosis (24) and thus contribute to elevation of periph-
eral neutrophil counts, serum levels of these cytokines were
studied by specific bioassays in mice .10 wk of age. Serum
levels of IL-3 and IL-6 but not GM-CSF were $20-fold
elevated in CD18 null mice; values for CD18 null versus
wild-type mice, respectively, were as follows: IL-3 mean
279 pg/ml (range 60–550; n 5 4) versus mean 52 pg/ml
(range 30–160; n 5 4) and IL-6 mean 715 pg/ml (range
Figure 2. Analysis of neutro-
phil adherence and respiratory
burst in wild-type and CD18
null mice. In A, adherence of
murine neutrophils to a KLH-
coated glass surface was mea-
sured as described in Materials
and Methods. Isolated neutro-
phils were incubated with PBS
or mAb for 30 min at room tem-
perature: 10 mg/ml Ml/70 (anti-
CD11b), 10 mg/ml KBA (anti-
CD11a), or 10 mg/ml SFDR5
(Ig-matched control Ab). ZAS
was added immediately before
injecting the cell mixture into
the adhesion chamber. Data are
presented as mean 6 SEM (n 5
3); P ,0.01 for wild-type (solid
bars) versus CD18 null (open bars) in absence of antibodies. B depicts chemiluminescence of neutrophils from wild-type and CD18 null mice. Isolated
neutrophils were mixed with 1028 M luminal before the addition of PBS or 0.5 mg/ml of freshly opsonized zymosan particles (OpZ). Result represents
mean 6 SEM (n 5 3); P ,0.01 for wild-type versus CD18 null with OpZ.
Table 1. Ig Concentrations in the Sera of Wild-type and CD18 
Null Mice
Ig Class
Mean 6 SD
Wild-type (n 5 6) CD18 null (n 5 6)
mg/ml
IgG total 705 6 312 18,162 6 9,049
IgG1 243 6 164 4,568 6 2,769
IgG2a 486 6 440 5,322 6 6,293
IgG2b 81 6 42 1,380 6 834
IgG3 234 6 45 397 6 104
IgM 116 6 6 242 6 66
IgA 1,463 6 149 2,310 6 448
IgE 162 6 197 335 6 223
Table 2. Leukocyte Counts in CD18 Null and Wild-type Mice
Cells
Mean 6 SD
Wild-type (n 5 6) CD18 null (n 5 4)
3 103/ml
Leukocytes 7.9 6 3.1 43.9 6 8.2
Neutrophils 2.2 6 1.5 24.0 6 10.4
Lymphocytes 5.2 6 3.1 18.0 6 2.8
Monocytes 0.23 6 0.08 0.87 6 0.16
Eosinophils 0.14 6 0.07 0.49 6 0.17
Basophils 0.04 6 0.02 0.15 6 0.02124 CD18 Null Mutation in Mice
562–1258, n 5 6) versus mean 42 pg/ml (range ,25–68, n 5
6). Phenotyping of CD4, CD8, and CD3 was performed
on T cells from spleen and thymus using FACSÒ analysis
(not shown), and no significant differences were found be-
tween CD18 null and wild-type mice indicating that
CD18 is not essential for T cell development.
Since LAD I patients have been reported to suffer from
bacterial infection, and because of observed perioral and
conjunctival lesions, oral and conjunctival cultures were
obtained from 12 CD18 null and 4 wild-type mice. All 16
oral cultures reflected the coprophagic behavior of mice
with various fecal contaminants. One of the four wild-type
conjunctival cultures was positive for Staphylococcus xylosus,
and the other three cultures were negative. All 12 conjunc-
tival cultures from the CD18 null mice were positive with
one to three organisms of commensal or fecal origin in-
Figure 3. Gross morphology and histology of CD18 null mice. A demonstrates alopecia in the neck and upper thorax with severe ulcerative dermatitis
and perioral soft tissue swelling. B shows extended facial alopecia and erosions with conjunctivitis of the eye. C demonstrates ulcerative dermatitis with
full thickness necrosis of the epidermis covered by an eosinophilic crust with entrapped inflammatory cells and bacterial colonies (arrows). There is adja-
cent epidermal hyperplasia. The dermal inflammatory infiltrate consists of lymphocytes, histiocytes, mast cells, occasional plasma cells, and few neutro-
phils. E, epidermis; D, dermis; and U, ulceration. Original magnification 2503. The spleen is shown in D with hyperplasia of the red pulp, multiple
plasma cells (*), and occasional Russell bodies (arrows), the latter indicative of abnormal deposition of immunoglobulins within plasma cells. Original mag-
nification 4003.125 Scharffetter-Kochanek et al.
cluding Escherichia coli, Lactobacillus species, Enterococcus faeca-
lis, Proteus mirabilis, Streptococcus, and Staphylococcus epidermi-
dis. The number of organisms increased with the severity of
conjunctivitis noted clinically. None of the fungal cultures
from six CD18 null and six wild-type mice showed any
growth. Conventional hematoxylin-eosin and Gram stain-
ing occasionally detected bacterial colonies on the crust of
erosions, but bacteria were not detected invading the tissue
beneath. Acid fast, PAS, and Grocott staining of skin sec-
tions failed to detect organisms below the surface.
Increased Mortality in CD18-deficient Mice Inoculated with S.
pneumoniae. Wild-type mice and CD18 null mice aged 8
wk were inoculated intraperitoneally with 6–8 3 106 CFU
of S. pneumoniae. There was a 53% survival by day 10 in
wild-type mice compared with no survival of CD18 mice
(P 5 0.003; Fig. 4). In wild-type mice, survivors cleared
bacteremia so that all animals were either dead or free of
bacteremia by day 10. In contrast, almost all blood cultures
were positive in CD18 null mice until death. CD18 null
mice consistently had a higher mean number of bacterial
colony forming units/10 ml in their blood cultures at vari-
ous times after inoculation with S. pneumoniae (167 6 145
at 24 h, 181 6 139 at 48 h, 177 6 126 at 72 h, 159 6 137
at 96 h, 157 6 142 at 120 h, 52 6 84 at 144 h, and 35 6
99 at 192 h) compared with wild-type mice (134 6 133 at
24 h, 58 6 99 at 48 h, 61 6 118 at 72 h, 24 6 68 at 96 h,
2.3 6 8.2 at 120 h, 9.0 6 30 at 144 h, and 0.0 6 192 h;
mean 6 SD); P value by log rank analysis ,0.0001. The
baseline leukocyte and neutrophil counts in the blood of
CD18 null mice were approximately four times those of
wild-type in these studies (compare to Table 1). In both
groups, the leukocyte counts dropped substantially in the
first 24 h after S. pneumoniae inoculation (54% decrease in
controls, 66% decrease in CD18 mice) and then increased
gradually. The neutrophil counts in the peritoneal fluid 48 h
after intraperitoneal inoculation of S. pneumoniae, though
not significant, were slightly increased in CD18 null mice
Figure 4. Increased bacteremia and mortality in CD18 null mice inoc-
ulated with S. pneumoniae. Mice were injected intraperitoneally with S.
pneumoniae as described in Materials and Methods. Significant increased
mortality (P 5 0.0003; solid bars) and increased bacteremia (hatched bars) in
surviving mice (P 5 ,0.0001) were found for CD18 null mice.
Figure 5. Neutrophil response
to toxic dermatitis. Ears were
challenged with topical applica-
tion of 10 ml 2% DNFB 5 h be-
fore death. The dense neutrophil
infiltrate in a wild-type mouse is
shown in A and the lack of neu-
trophil response despite the pres-
ence of edematous interstitial tis-
sue is shown in a CD18 null
mouse in B. Hematoxylin and
eosin staining at an original mag-
nification of 4003 is shown.
Dermis (d) and cartilage (c) are
labeled.126 CD18 Null Mutation in Mice
compared with wild-type indicating that significant num-
bers of neutrophils can emigrate in the complete absence of
CD18. Thus, CD18 null mice demonstrated a marked in-
crease in susceptibility to death from bacteremia after inoc-
ulation with S. pneumoniae.
Neutrophil Emigration Is impaired in Toxic Dermatitis. As re-
ported earlier for bovine and human LAD (25–27), we de-
tected extremely low numbers of neutrophils in the inter-
stitial connective tissue beneath the spontaneously occurring
skin erosions in CD18 null mice (Fig. 3 C). To study neu-
trophil extravasation in a more controlled fashion, we in-
duced a toxic dermatitis by applying 2% DNFB onto the
ear of mice and studied neutrophil extravasation at 5 h after
application of the irritant. A severe toxic response was ob-
served both in CD18 null mice and in littermate controls
with spongiosis of the epidermis and edema formation
within the dermis. However, although many neutrophils
were detected in the interstitial connective tissue in wild-
type mice (Fig. 5 A), virtually no neutrophils were seen
within the dermis of CD18 null mice (Fig. 5 B). In CD18
null mice, neutrophils were seen within the lumen of der-
mal vessels.
Intravital Microscopy Reveals Reduction of Firm Adhesion in
Venules. To elucidate the mechanism underlying the lack
of neutrophil extravasation, intravital microscopy was per-
formed. Firm cell attachment to the endothelial lining of
the studied vessels did not occur in wild-type or CD18 null
mice without stimulation by N-formyl-methionyl-leucyl-
phenylalanine (fMLP; Fig. 6, A and B). Microinjection of
fMLP resulted in a large increase in firm cell adherence in
wild-type mice (Fig. 6, C and E), but no increase was ob-
served in CD18 null mice upon fMLP stimulation (Fig. 6,
D and E). Spontaneous rolling of cells occurred both in
wild-type and in CD18 null mice, though in CD18 null to
a significantly greater extent, most likely reflecting the dra-
matic increase in the peripheral leukocyte numbers (Fig. 6
F). Although rolling was significantly reduced in wild-type
mice upon fMLP stimulation reflecting induction of firm
adhesion, no significant decrease in the number of rolling
cells was detected in CD18 null mice upon fMLP stimula-
tion. The intravital microscopy and analysis of toxic derma-
titis indicate that CD18 is required for leukocyte adhesion
and emigration in these settings.
CD18 Plays a Major Role in TCR-dependent T Cell Prolif-
eration. We evaluated the importance of CD18 in T cell
activation when the TCR was stimulated in the MLR or
with staphylococcal enterotoxin A (SEA). Unfractionated
spleen cells were irradiated and used as antigen-presenting
stimulators, whereas T cells isolated from spleen were used
as responder cells. Cells from CD18 null and wild-type
mice were of mixed C57BL/6J and 129/Sv background
(both H-2b), whereas cells from BALB/c mice express H-2d.
T cells from wild-type littermates demonstrate a prolif-
erative response to allogeneic stimulation with irradiated
BALB/c cells; no proliferative response was observed with
syngeneic stimulator cells (Fig. 7 A). There was no detect-
able proliferation of T cells derived from CD18 null mice
with allogeneic or syngeneic stimulator cells (Fig. 7 B). The
T cell response was evaluated further by quantitating the
concentration-dependent proliferative response to SEA.
When T cells from wild-type mice were exposed to SEA,
the maximal [3H]thymidine incorporation ranged from
35,000 to 80,000 cpm at SEA concentrations between 1–10
ng/ml. However, even at an SEA concentration of 10 mg/ml,
[3H]thymidine incorporation was below 10,000 cpm in T
cells derived from CD18 null mice (Fig. 8 A). Stimulation
of cells with phorbol myristate acetate and ionomycin
demonstrated that cells from CD18 null mice were capable
of proliferating normally, if the requirement for the T cell
receptor was bypassed (Fig. 8 B). These data indicate that
CD18 serves a critical role in generating a T cell prolifera-
tive response to MHC alloantigens or to SEA.
Figure 6. Firm attachment and rolling of leukocytes is altered in CD18
null mice. Intravital microscopy was performed as described in Materials
and Methods. Venules with diameters between 20 and 40 mm were ob-
served and recorded through a CCD camera. Almost no firm attachment
of leukocyte occurred in a wild-type mouse before fMLP infusion (A).
Infusion of fMLP resulted in a substantial increase in firmly attached leu-
kocytes in a wild-type mouse (C). No firm attachment of leukocytes to
the endothelial lining was observed in CD18 null mice before or after
fMLP stimulation (B and D, respectively). The number of firmly adherent
leukocytes in the observed vessels was quantitated before fMLP infusion
and 1 min after infusion (E). Results are presented as number of firmly
adherent cells/100 mm of vessel length. Rolling leukocyte fluxes were de-
termined before fMLP infusion and 1 min after infusion (F ). Results
(mean 6 SEM, n 5 3) are expressed as the flux of rolling leukocytes per
minute.127 Scharffetter-Kochanek et al.
Discussion
The CD18 null mouse reported here displays a pheno-
type which is generally similar to that seen for human (4, 7)
and bovine (5, 6) LAD I. The common features include
leukocytosis, spontaneous skin infections, and impaired em-
igration of neutrophils at sites of infection. Impaired adher-
ence of neutrophils and respiratory burst is similar in CD18
deficient mice and humans. Mutations in humans are het-
erogeneous, and hypomorphic mutations result in milder
LAD I phenotypes. The hypomorphic mutation in the
mouse is associated with 2–16% of normal levels of CD18
on leukocytes (8) and is analogous to mild or moderate
forms of human LAD I. The hypomorphic mouse muta-
tion may be more appropriate for chronic studies of the
role of CD18 in inflammatory disease processes, while the
null mutation reported here will be more valuable for de-
termining whether CD18 is essential for a particular leuko-
cyte function. Studies with mutant mice complement func-
tional analyses with blocking antibodies most often confirming
but occasionally questioning (28–31) the role of an adhe-
sion molecule in specific leukocyte activities.
Mouse mutations in numerous leukocyte and endothelial
cell adhesion molecules have been prepared including leu-
kocyte integrins, immunoglobulin family members (ICAM-1,
VCAM-1), selectins, and selectin ligands (32–35). Muta-
tions in CD11a (10) and CD11b (11, 12) are of particular
interest, since they would affect the subsets of CD18 func-
tions attributable to LFA-1 and Mac-1, respectively. Mice
with CD11a deficiency were found to have a moderate de-
fect in peritoneal emigration at early times, reduced natural
killer cytotoxicity, normal immunoglobulin levels, reduced
responder cell function in MLR, normal CTL responses to
virus, and impaired rejection of tumor cells (10). Mice defi-
cient in CD11b show normal or increased peritoneal emi-
gration, delayed apoptosis of extravasated leukocytes, im-
paired neutrophil degranulation and binding of neutrophils
to fibrinogen, and reduced neutrophil phagocytosis and oxy-
gen-free radical generation (11, 12).
Mice with deficiency of ICAM-1 or individual selectins
are viable and do not develop spontaneous infections under
laboratory conditions, but these mutants show varying ab-
Figure 7. Abrogation of mixed
lymphocyte reaction in CD18
null mice. Splenocytes from three
wild-type littermate controls (A)
and from three CD18 null mice
(B) were stimulated in a mixed
lymphocyte reaction. Responder
cells (4 3 105 cells per well)
were mixed with increasing con-
centrations of allogeneic BALB/c
(filled symbols) or with syngeneic
wild-type or CD18 null spleen
cells that had been irradiated
(open symbols). Analysis of prolif-
eration was performed after 96 h
in culture as described in Materi-
als and Methods. Data are pre-
sented as mean cpm 6 SEM of
triplicate cultures.
Figure 8. Abrogation of T cell
proliferation in response to staph-
ylococcal enterotoxin A (SEA) in
CD18 null mice. In A, spleno-
cytes from three wild-type litter-
mates (filled symbols) and from
CD18 null mice (open symbols)
were cultured without addition
or with 0.1 ng to 20 mg/ml SEA.
In B, splenocytes from wild-type
(filled symbols) or CD18 null (open
symbols) mice were stimulated with
100 ng/ml phorbol myristate ac-
etate and 200 ng/ml ionomycin
and analyzed for proliferation at
the indicated times. Prolifera-
tion was quantitated as described
in Materials and Methods and is
expressed as mean cpm 6 SEM
of triplicate cultures for three
mice of each genotype.128 CD18 Null Mutation in Mice
normalities of leukocyte adhesion, migration, and rolling;
see (32–35) for review and references. Mice with double
deficiency of P-selectin and E-selectin do develop sponta-
neous cutaneous infections (36, 37), thus sharing some
phenotypic features in common with LAD I. A rare human
disorder affecting fucose metabolism causes leukocyte ad-
hesion deficiency II (LAD II) apparently through an effect
on carbohydrate structure of selectin ligand molecules (38).
The increased susceptibility to infection in CD18 null
mice emphasizes the importance of granulocytes and mac-
rophages as an antigen-independent first line of defense in
response to pathogens or tissue injury. There is ample evi-
dence that CD18 is important for the initial emigration of
leukocytes, and it is not surprising that spontaneous cutane-
ous infections occur in the CD18 null mice, particularly
given the previous information from humans and cattle. A
systemic infectious challenge using intraperitoneal injection
of S. pneumoniae demonstrated the increased infectious sus-
ceptibility of the CD18 null mice. These mice had essen-
tially no ability to clear bacteremia and survive the infec-
tious inoculation. Although mice with deficiency of ICAM-1
or individual selectins do not develop spontaneous infec-
tions as mentioned above, mice with individual deficiencies
of E-selectin or P-selectin demonstrate increased morbidity
and mortality using the S. pneumoniae inoculation protocol
described here for the CD18 null mice (14). The increased
mortality in CD18 null mice inoculated with S. pneumonia
is not accompanied by a severe defect in neutrophil emi-
gration, since approximately similar numbers of neutrophils
were found in the peritoneal fluid compared with wild-
type mice. This CD18-independent emigration is also seen
in CD11b-deficient mice with a thioglycolate-induced
peritonitis (11), and the data from CD18- and CD11b-defi-
cient mice are consistent with the interpretation that neu-
trophils emigrating by CD18-independent pathways have
different properties, do not function normally, and are not
as effective in eliminating bacteria. Thus, although mice
with individual deficiencies of leukocyte and endothelial
cell adhesion molecules may not develop spontaneous in-
fection under laboratory conditions, deficiency of these
molecules probably causes more subtle susceptibility to in-
fection in almost all cases. It is likely that susceptibility to
infection provides a major pressure for evolutionary con-
servation of these molecules.
The complete deficiency of CD18 leads to severe abnor-
malities of leukocyte adhesion and activation. These in
vitro abnormalities correlate with severe reductions in the
ability of neutrophils to migrate in to sites of spontaneously
occurring cutaneous infection or in response to toxic der-
matitis. The deficiency of CD18 also leads to a substantial
reduction of firm adherence as evaluated by intravital mi-
croscopy. However, the in vivo role of CD18 in leukocyte
emigration is extremely complex with the clear existence
of CD18-independent pathways. Using the CD18 null mice
reported here, neutrophil emigration in response to irritant
dermatitis due to croton oil was severely impaired, in
agreement with our results with DNFB-induced dermati-
tis, but emigration was normal or enhanced during perito-
nitis induced by either thioglycolate or S. pneumoniae or
with pneumonia induced by S. pneumoniae or E. coli (31).
Although the normal or enhanced emigration of neutro-
phils in CD18 null mice is somewhat surprising, the data
reported here and those of Mizgard et al. (31) are consistent
with prominent dependence on CD18 for emigration into
soft tissues, variable dependence on CD18 in peritonitis
models, and lesser dependence on CD18 for pulmonary al-
veolar emigration. There is clear evidence for CD18-
independent pathways of emigration, and perhaps these al-
ternative mechanisms are more readily induced in animals
with severe defects in the function of leukocyte and endo-
thelial cell adhesion molecules as exemplified by the CD18
null mice and P-selectin/E-selectin double mutant mice
(36, 37), both of which develop spontaneous skin disease.
The hypothesis has been forwarded that neutrophils ini-
tially infiltrating the inflammatory site, via the release of
major T cell and macrophage chemoattractants, set the
stage for the switch in the type of leukocyte infiltration
typically occurring during the evolution of the inflamma-
tory response from acute to chronic stage (39). The CD18
null mice demonstrate that the lack of initiating signals
from egressed neutrophils does not prevent the develop-
ment of the chronic mononuclear cell infiltrate in sponta-
neously occurring erosions and toxic dermatitis. However,
cell populations of the chronic infiltrate are not able to pre-
vent the ulcerative dermatitis.
A major finding resulting from the analysis of these mice
was the recognition that CD18 deficiency causes a severe
defect in T cell proliferation in response to stimulation of
T cell receptors. Although CD11/CD18 integrins are ac-
cepted as playing a costimulatory role in the function of
T cell receptors, their importance is often implied to be less
than for CD28/B7. The defect in the CD18 null mice in-
dicates an essential role for CD11/CD18 integrins in the
response of T cell receptors under the conditions exam-
ined. CD18 null T cells fail to proliferate in response to the
potent stimulus of SEA, which typically activates large sub-
families of T cells by interaction with common T cell re-
ceptor Vb elements. Proliferative responses to allogeneic
MHC determinants are similarly abolished. However, ele-
vated serum Ig levels, particularly of certain IgG isotypes
and to a lesser extent IgA, suggest that CD18 null T cell
responses to at least some conventional peptide antigens
occur and provide the cytokine and T cell membrane func-
tions required to achieve B cell growth and isotype
switching.
A significant role of the CD11a/CD18(LFA-1) receptor
in SE response has been suggested previously. Antibodies
blocking CD18, CD11a, or ICAM-1 each block SE-induced
T cell growth and cytokine production (40, 41). Addition-
ally, transfected or purified ICAM-1 restores SE-induced T
cell growth under nonpermissive conditions. Other mole-
cules that simply provide adhesion are ineffective, suggest-
ing that distinct costimulatory functions are provided through
LFA-1 binding (42, 43). Naive or resting, rather than
memory T cells are particularly dependent upon LFA-1 co-
stimulation (43). LFA-1 ligation causes increased expression129 Scharffetter-Kochanek et al.
of the well-recognized CD28/B7 costimulatory molecules
on these cells (44) and may in part account for the role of
CD28 in SE-induced proliferation (45–48). Thus the present
work indicates that CD181 receptors provide essential early
signaling events in SE responses that are not bypassed by
other costimulator systems of CD18 null T cells.
Similarly, antibody blocking and transfection studies
have suggested a predominant role of the CD11a/CD18:
ICAM-1 interaction in T cell responses to allogeneic MHC
molecules (40, 44, 45, 49). Moreover, mice deficient in
CD11a or ICAM-1 exhibit profound depression of MLR
response when used as responder and stimulator popula-
tions respectively (10, 50). The present findings indicate
that CD18 similarly plays a critical role in the capacity of T
cells to respond to allogeneic MHC determinants. As in SE
responses, naive alloreactive T cells appear to be critically
dependent upon LFA-1 costimulation (44). In contrast, al-
loreactive memory T cells can exhibit apoptosis rather than
growth upon coligation of LFA-1 and TCR (51). Thus,
CD18 null T cells activated by bacterial or other antigens
that bypass an initial role of CD18 may manifest dysregu-
lated responses and thereby contribute to elevated cytokine
and Ig production and chronic inflammation.
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